XML 29 R11.htm IDEA: XBRL DOCUMENT
v3.24.1

Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2023
Payables and Accruals [Abstract] |
Accrued Expenses | (5) Accrued Expenses Accrued expenses at December 31, 2023 and 2022 consist of the following: Schedule of Accrued Expenses
|  | 2023 |  |  | 2022 |
|  | (in thousands) December 31, |
|  | 2023 |  |  | 2022 |
Compensation |  | $ | 414 |  |  | $ | 1 |
Professional fees |  |  | 1,352 |  |  |  | 492 |
Clinical trial expenses |  |  | 184 |  |  |  | 110 |
Other expenses |  |  | 36 |  |  |  | 203 |
Total |  | $ | 1,986 |  |  | $ | 806 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration